Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Oberaigner, Willi ^a,b,c   Buchberger, Wolfgang ^b,d   Frede, Thomas ^c   Knapp, Rudolf ^e   Marth, Christian ^c   Siebert, Uwe ^b,c,f,g  

^a Tyrolean State Hospitals Ltd   (Austria)

^b UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e Kufstein County Hospital   (Austria)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; BREAST TUMOR; CANCER STAGING; COHORT ANALYSIS; FEMALE; HUMAN; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; MORTALITY; POISSON DISTRIBUTION; RADIOGRAPHY; REGISTER; REGRESSION ANALYSIS;

ADULT; AGE DISTRIBUTION; AGED; AUSTRALIA; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; MORTALITY; NEOPLASM STAGING; POISSON DISTRIBUTION; REGISTRIES; REGRESSION ANALYSIS;

EID: 77649319387     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-86     Document Type: Article

References (41)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
2. European guidelines for quality assurance in breast cancer screening and diagnosis. N Perry M Broeders C de Wolf (eds), et al. Luxembourg: Office for Official Publication of the European Communities Fourth 2006
3. sterr. Gesundheitsbefragung 2006/07. Wien: Statistik sterreich 2008 (In German: Health Survey in Austria 2006/07)
4. Bias associated with self-report of prior screening mammography. KA Cronin DL Miglioretti M Krapcho B Yu BM Geller PA Carney, et al. Cancer Epid Biom Prev 2009 18 6 1699 705 10.1158/1055-9965.EPI-09-0020
5. Opportunistic breast cancer early detection in Tyrol, Austria 1996-2004. Is a mammography-screening program necessary? TE Frede, Eur J Radiol 2005 55 1 130 8 10.1016/j.ejrad.2005.04.019 15925467
6. Breast cancer trends: opportunistic screening in Austria versus controlled screening in Finland and Sweden. C Vutuc T Waldhoer G Haidinger, Eur J Cancer Prev 2006 15 4 343 6 10.1097/00008469-200608000-00007 16835504
7. Tumorregister Tirol Bericht für die Diagnosejahre 2004/2006. W Oberaigner H Mühlböck L Harrasser, Innsbruck: IET-Bericht 2008 (In German)
8. Qualitätsaspekte der Todesursachenstatistik. B Leitner, Statist Nachrichten 2005 9 790 7 (In German)
9. Cancer Incidence in Five Continents. Volume VIII. DM Parkin SL Whelan J Ferlay L Teppo B Thomas, Lyon: IARC 2002
10. Cancer Incidence in Five Continents. MP Curado B Edwards HR Shin H Storm J Ferlay J Heanue P Boyle, (IARC Scientific Publications No. 160). Lyon: IARC 2007 IX
11. Models for temporal variation in cancer rates. I: Age-period and age-cohort models. D Clayton E Schifflers, Stat Med 1987 6 4 449 67 10.1002/sim.4780060405 3629047
12. Models for temporal variation in cancer rates. II: Age-period-cohort models. D Clayton E Schifflers, Stat Med 1987 6 4 469 81 10.1002/sim.4780060406 3629048
13. Stata Statistical Software. Release 9.0. College Station, TX: StataCorp LP 2005
14. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. World Medical Association, http://www.wma.net/en/30publications/10policies/b3/index.html (accessed 7 November 2009)
15. Are survival rates for Tyrol published in the Eurocare studies biased? W Oberaigner U Siebert, Act Oncol 2009 48 7 984 91 10.1080/02841860903188635
16. Factors related to non-participation in a population-based breast cancer screening programme. ML Baré J Montes F Florensa M Sentís L Donoso, Eur J Cancer Prev 2003 12 6 487 94 10.1097/00008469-200312000-00007 14639126
17. Predicting the future burden of cancer. F Bray B Moller, Nat Rev Cancer 2006 6 1 63 74 10.1038/nrc1781 16372017
18. Understanding the effects of age, period, and cohort on incidence and mortality rates. TR Holford, Annu Rev Public Health 1991 12 425 57 10.1146/annurev.pu.12.050191.002233 2049144
19. The Decrease in Breast-Cancer Incidence in 2003 in the United States. PM Ravdin KA Cronin N Howlader CD Berg RT Chlebowski EJ Feuer, et al. NEM 2007 356 16 1670 4 10.1056/NEJMsr070105
20. IARC Handbooks of Cancer Prevention: Breast Cancer Screening. Lyon: IARC-Publications 2002 7
21. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. RG Blanks SM Moss CE McGahan MJ Quinn PJ Babb, BMJ 2000 321 7262 665 9 10.1136/bmj.321.7262.665 10987769
22. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality. A systematic review. SJ Otto J Fracheboud CWN Looman MJM Broeders R Boer JHCL Hendriks, et al. Lancet 2003 361 1411 17 10.1016/S0140-6736(03)13132-7 12727393
23. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer. H Jonsson L Nyström S Törnberg P Lenner, J Med Screen 2001 8 152 60 10.1136/jms.8.3.152 11678556
24. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. SW Duffy L Tabar HH Chen M Holmqvist MF Yen S Abdsalah, et al. Cancer 2002 95 458 69 10.1002/cncr.10765 12209737
25. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. L Nyström I Andersson N Bjurstam J Frisell B Nordenskjöld LE Rutqvist, Lancet 2002 359 909 19 10.1016/S0140-6736(02) 08020-0 11918907
26. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. AH Olsen SH Njor I Vejborg W Schwartz P Dalgaard MB Jensen, et al. BMJ 2005 330 7485 220 10.1136/bmj.38313.639236.82 15649904
27. Screening for Breast cancer with Mammography. PC Gotzsche M Nielsen, Cochrane Database of Systematic Reviews 2006 4 D001877
28. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. A Anttila J Koskela M Hakama, J Med Screen 2002 9 4 153 8 10.1136/jms.9.4.153 12518004
29. Results from the UK NHS breast screening programme 1994-1999. RG Blanks SM Moss J Patnick, J Med Screen 2000 7 4 195 8 10.1136/jms.7.4.195 11202586
30. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. M Hakama E Pukkala M Heikkila M Kallio, BMJ 1997 314 7084 864 7 9093096
31. Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data. The Swedish Organised Service Screening Evaluation Group, Cancer Epidem Bio Prev 2006 15 1 45 51 10.1158/1055-9965.EPI-05-0349
32. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes. S Törnberg J Carstensen T Hakulinen P Lenner T Hatschek B Lundgren, J Med Screen 1994 1 184 7 8790514
33. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. R Peto J Boreham M Clarke C Davies V Beral, Lancet 2000 355 9217 1822 10.1016/S0140-6736(00)02277-7 10832853
34. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer. DA Berry KA Cronin SK Plevritis DG Fryback L Clarke M Zelen, et al. NEJM 2005 353 17 1784 92 10.1056/NEJMoa050518 16251534
35. Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. E Paci SW Duffy D Giorgi M Zappa E Crocetti V Vezzosi, et al. Br J Cancer 2002 87 1 65 9 10.1038/sj.bjc.6600301 12085258
36. Breast cancer screening for women aged 40 to 49 years - what does the evidence mean for New Zealand? S Baker M Wall A Bloomfield, N Z Med J 2005 118 1221 1628 16138166
37. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. TM Kolb J Lichy JH Newhouse, Radiology 2002 225 1 165 75 10.1148/radiol.2251011667 12355001
38. Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. M Nothacker V Duda M Hahn M Warm F Degenhardt H Madjar S Weinbrenner US Albert, BMC Cancer 2009 9 335 10.1186/1471-2407-9-335 19765317
39. Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. W Buchberger A Niehoff P Obrist P DeKoekkoek-Doll M Dunser, Semin Ultrasound CT MR 2000 21 4 325 36 10.1016/S0887-2171(00)90027-1 11014255
40. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. JS Mandelblatt KA Cronin S Bailey, et al. Ann Intern Med 2009 151 10 738 47 19920274
41. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009 151 10 716 26 19920272